MRI substudy
Deadline:20 Feb 2026, 00:00 CET
Tender information
TED EULeipzig, Germany
- Type
- 16
- Procedure
- neg-w-call
- Ref. number
- 78959-2026
- CPV
- 73000000
PRImus-AD is a Phase II clinical trial investigating the efficacy and safety of an innovative drug in patients with mild cognitive impairment or mild Alzheimer's dementia.